Twice-Yearly Biologic Effective Against Nasal Polyps

TribeNews
0 Min Read

MedPage Today) — SAN DIEGO — Novel ultra-long-acting biologic depemokimab reduced nasal polyps in chronic rhinosinusitis, two parallel phase III trials showed.
Twice-yearly injections cut total nasal polyps score by a mean of 0.7 more than…

Leave a Comment
Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected & This Is Prohibited!!!

We have detected that you are using extensions to block ads and you are also not using our official app. Your Account Have been Flagged and reported, pending de-activation & All your earning will be wiped out. Please turn off the software to continue

You cannot copy content of this app